Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Maurizio Scaltriti
Based on 38 articles published since 2009
(Why 38 articles?)
||||
Expertise Level
The expertise of Maurizio Scaltriti ranks in the
  • Top 0.29%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 38 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Scaltriti, Maurizio   ·   Scaltriti, M
Work Locations
Details
Most likely:    Memorial Sloan-Kettering Cancer Center   Contact    
2018
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA. · Department of Pathology, MSKCC, New York, NY 10065, USA. · Weill-Cornell Medical College, New York, NY 10065, USA. · Department of Epidemiology and Biostatistics, MSKCC, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Department of Pathology, MSKCC, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. Electronic address: · Pubmed 30537512
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain. · Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 08035 Barcelona, Spain. · Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Wagistrasse 18, 8952 Schlieren, Switzerland. · Translational Research Program, VHIO, 08035 Barcelona, Spain. · Clinical Research Program, VHIO, 08035 Barcelona, Spain. · Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Monogram Biosciences, Laboratory Corporation of America Holdings, South San Francisco, CA 94080, USA. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain. · Medical Oncology Service, Hospital del Mar, 08003 Barcelona, Spain. · Universitat Pompeu Fabra, 08003 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona, Campus de la UAB, 08193 Bellaterra, Spain. · Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain. · Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain. · Pubmed 30282693
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 30205045
  • Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298. · Department of Pathology, Virginia Commonwealth University School of Medicine, Richmond, VA 23220. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Molecular & Systems Biology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756. · Preclinical Research Program, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Centro de Investigación Biomédica en Red en Oncologia (CIBERONC), 08035 Barcelona, Spain. · Department of Medicine, Massachusetts General Hospital, Cancer Center and Harvard Medical School, Boston, MA 02129. · Oncology Discovery Department, AbbVie Inc., North Chicago, IL 60064. · Division of Hematology, Oncology and Palliative Care, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298. · Oncology Development Department, AbbVie Inc., North Chicago, IL 60064. · Department of Oncological Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona, Campus de la UAB, 08193 Bellaterra, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer, 08036 Barcelona, Spain. · Department of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298-0032. · Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298; · Pubmed 29476008
  • Department of Medical, Surgical and Health Sciences, Teaching Hospital of Cattinara, University of Trieste, Trieste, Italy. · Department of Medical, Surgical and Health Sciences, University of Trieste, Cattinara Academic Hospital, Trieste, Italy. · Department of Oncology, Medical Oncology Unit, San Donato Hospital, Arezzo, Italy. · Department of Radiation Oncology, Peter MacCallum Cancer Center, Moorabbin Campus, Bentleigh East, Victoria, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29345357
2017
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Computational Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, NY 10065, USA. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, 1450 3rd Street, San Francisco, CA 94158, USA. · Microchemistry and Proteomics Core Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 28336670
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2016
  • Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. · Unit of Investigative Clinical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore. · Medical Oncology, Ospedale Civile di Saluzzo, Saluzzo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543, Singapore; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. Electronic address: · Pubmed 26645663
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain; Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Department of Structural Immunology, Institute of Innate Immunity, University of Bonn, 53127 Bonn, Germany; Group Physical Biochemistry, Center of Advanced European Studies and Research, 53175 Bonn, Germany. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital and Harvard Medical School, Boston, MA 02215, USA. · Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. · Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Pubmed 27880910
  • Breast Cancer Now Research Unit, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, Guy's Hospital, London, UK. · Cancer Bioinformatics, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Oncology iMed, AstraZeneca, Waltham, Massachusetts, USA. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 27775704
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · The Broad Institute of MIT and Harvard, Cambridge, MA. · Division of Hematology Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, NewYork, NY. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Brigham and Women's Hospital, Boston MA. · Pubmed 27604488
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra (Cerdanyola del Vallès), Spain. · OncoPlex Diagnostics (Division of NantOmics, LLC), 9600 Medical Center Drive, Suite 300, Rockville, MD 20850, USA. · Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Department of Pathology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 26422389
2015
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, Barcelona, 08035, Spain. · Universitat Autònoma de Barcelona, Barcelona, 08035, Spain. · ERTICa Research Group, University of Auvergne EA4677, 63000, Clermont-Ferrand, France. · Biopathology, Jean Perrin Comprehensive Cancer Center, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Richard Dimbleby Department of Cancer Research, Randall Division of Cell and Molecular Biophysics and Division of Cancer Studies, King's College London, London, SE1 1UL, UK. · UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital King's College London School of Medicine, London, SE1 9RT, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY, 10065, USA. · Pubmed 25887735
  • Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain · Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science Scotland, Kincraig, UK. · BrEAST Data Centre, Jules Bordet Institute, Brussels, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · GlaxoSmithKline, Collegeville, USA. · University Hospital Kiel, Kiel, Germany. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York Breast Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25851628
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts 02114, USA. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [2] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [3] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Howard Hughes Medical Institute, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland. · Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [4] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Pubmed 25409150
2014
  • Breast Cancer Unit, Vall d׳Hebron Institute of Oncology, Vall d׳Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY. Electronic address: · Pubmed 25440604
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Clinical Research, Monogram Biosciences, Inc., 345 Oyster Point Blvd., South San Francisco, CA, USA. · Laboratory of Cell Therapy, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Candiolo, Italy. · A.O. Città della Salute e della Scienza di Torino - sede Molinette, C.so Bramante 88/90, 10126 Torino, Italy. · Department of Biological Sciences and Human Oncology, Universita di Torino, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address: · Pubmed 24075779
  • Genus Oncology, Boston, MA, USA. · Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 23912457
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
2013
  • Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 23903756
2011
  • Program in Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21215704
Probable:    NewYork-Presbyterian Hospitals      
2017
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
Probable:    Harvard University Boston   Contact    
2012
  • Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA. · Pubmed 22718860
2014
  • 1Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA. · Pubmed 24667376
2012
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 22393084
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 38 total) written by Maurizio Scaltriti about Breast Neoplasms:

  • Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway. 2018
  • Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2). 2018
  • p95HER2-T cell bispecific antibody for breast cancer treatment. 2018
  • The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. 2018
  • Coamplification of 2018
  • The prognostic value of PI3K mutational status in breast cancer: A meta-analysis. 2018
  • PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. 2017
  • Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence. 2017
  • AKT signaling in ERBB2-amplified breast cancer. 2016
  • CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Maurizio Scaltriti using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Memorial Sloan-Kettering Cancer Center
NewYork-Presbyterian Hospitals
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Memorial Sloan-Kettering Cancer Center
2018
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA. · Department of Pathology, MSKCC, New York, NY 10065, USA. · Weill-Cornell Medical College, New York, NY 10065, USA. · Department of Epidemiology and Biostatistics, MSKCC, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Department of Pathology, MSKCC, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. Electronic address: · Pubmed 30537512
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain. · Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 08035 Barcelona, Spain. · Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Wagistrasse 18, 8952 Schlieren, Switzerland. · Translational Research Program, VHIO, 08035 Barcelona, Spain. · Clinical Research Program, VHIO, 08035 Barcelona, Spain. · Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Monogram Biosciences, Laboratory Corporation of America Holdings, South San Francisco, CA 94080, USA. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain. · Medical Oncology Service, Hospital del Mar, 08003 Barcelona, Spain. · Universitat Pompeu Fabra, 08003 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona, Campus de la UAB, 08193 Bellaterra, Spain. · Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain. · Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain. · Pubmed 30282693
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 30205045
  • Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298. · Department of Pathology, Virginia Commonwealth University School of Medicine, Richmond, VA 23220. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Molecular & Systems Biology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756. · Preclinical Research Program, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Centro de Investigación Biomédica en Red en Oncologia (CIBERONC), 08035 Barcelona, Spain. · Department of Medicine, Massachusetts General Hospital, Cancer Center and Harvard Medical School, Boston, MA 02129. · Oncology Discovery Department, AbbVie Inc., North Chicago, IL 60064. · Division of Hematology, Oncology and Palliative Care, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298. · Oncology Development Department, AbbVie Inc., North Chicago, IL 60064. · Department of Oncological Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona, Campus de la UAB, 08193 Bellaterra, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer, 08036 Barcelona, Spain. · Department of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298-0032. · Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298; · Pubmed 29476008
  • Department of Medical, Surgical and Health Sciences, Teaching Hospital of Cattinara, University of Trieste, Trieste, Italy. · Department of Medical, Surgical and Health Sciences, University of Trieste, Cattinara Academic Hospital, Trieste, Italy. · Department of Oncology, Medical Oncology Unit, San Donato Hospital, Arezzo, Italy. · Department of Radiation Oncology, Peter MacCallum Cancer Center, Moorabbin Campus, Bentleigh East, Victoria, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29345357
2017
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Computational Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, NY 10065, USA. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, 1450 3rd Street, San Francisco, CA 94158, USA. · Microchemistry and Proteomics Core Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 28336670
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
2016
  • Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. · Unit of Investigative Clinical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore. · Medical Oncology, Ospedale Civile di Saluzzo, Saluzzo, Italy. · Bioinformatics Institute (A*STAR), #07-01 Matrix, 30 Biopolis Street #07-01, 138671, Singapore; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543, Singapore; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Memorial Sloan Kettering Cancer Center (MSKCC), Human Oncology and Pathogenesis Program (HOPP), NY, USA. Electronic address: · Pubmed 26645663
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain; Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Department of Structural Immunology, Institute of Innate Immunity, University of Bonn, 53127 Bonn, Germany; Group Physical Biochemistry, Center of Advanced European Studies and Research, 53175 Bonn, Germany. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital and Harvard Medical School, Boston, MA 02215, USA. · Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. · Department of Radiation Oncology and Center for DNA Damage and Repair, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. · Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Health Network, Darlinghurst, NSW 2010, Australia. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Pubmed 27880910
  • Breast Cancer Now Research Unit, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, Guy's Hospital, London, UK. · Cancer Bioinformatics, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Oncology iMed, AstraZeneca, Waltham, Massachusetts, USA. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 27775704
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · The Broad Institute of MIT and Harvard, Cambridge, MA. · Division of Hematology Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, NewYork, NY. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Brigham and Women's Hospital, Boston MA. · Pubmed 27604488
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra (Cerdanyola del Vallès), Spain. · OncoPlex Diagnostics (Division of NantOmics, LLC), 9600 Medical Center Drive, Suite 300, Rockville, MD 20850, USA. · Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Department of Pathology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 26422389
2015
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, Barcelona, 08035, Spain. · Universitat Autònoma de Barcelona, Barcelona, 08035, Spain. · ERTICa Research Group, University of Auvergne EA4677, 63000, Clermont-Ferrand, France. · Biopathology, Jean Perrin Comprehensive Cancer Center, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Richard Dimbleby Department of Cancer Research, Randall Division of Cell and Molecular Biophysics and Division of Cancer Studies, King's College London, London, SE1 1UL, UK. · UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital King's College London School of Medicine, London, SE1 9RT, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY, 10065, USA. · Pubmed 25887735
  • Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain · Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science Scotland, Kincraig, UK. · BrEAST Data Centre, Jules Bordet Institute, Brussels, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · GlaxoSmithKline, Collegeville, USA. · University Hospital Kiel, Kiel, Germany. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York Breast Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25851628
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts 02114, USA. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [2] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [3] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Howard Hughes Medical Institute, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland. · Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA. · 1] Department of Genetics, Washington University School of Medicine, 4566 Scott Avenue, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [3] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [4] Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. · 1] Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA [2] Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, New York 10065, USA. · Pubmed 25409150
2014
  • Breast Cancer Unit, Vall d׳Hebron Institute of Oncology, Vall d׳Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY. Electronic address: · Pubmed 25440604
  • Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy; Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Medical Oncology, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Str. Provinciale 142, 10060 Candiolo, Italy. · Clinical Research, Monogram Biosciences, Inc., 345 Oyster Point Blvd., South San Francisco, CA, USA. · Laboratory of Cell Therapy, Fondazione del Piemonte per l'Oncologia, Institute of Candiolo (IRCCs), Candiolo, Italy. · A.O. Città della Salute e della Scienza di Torino - sede Molinette, C.so Bramante 88/90, 10126 Torino, Italy. · Department of Biological Sciences and Human Oncology, Universita di Torino, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address: · Pubmed 24075779
  • Genus Oncology, Boston, MA, USA. · Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 23912457
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
2013
  • Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 23903756
2011
  • Program in Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21215704
NewYork-Presbyterian Hospitals
2017
  • Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Breast Medicine Service, Department of Medicine, MSKCC, New York, NY, USA. · Weill Cornell Medical College, New York, NY USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. · Pubmed 27748766
Harvard University Boston
2012
  • Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA. · Pubmed 22718860
2014
  • 1Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA. · Pubmed 24667376
2012
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 22393084
Vall d'Hebron Research Institut de Recerca
2011
  • Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21383049
  • Departments of Medical Oncology and Molecular Pathology, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Pubmed 21321214
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
2013
  • Experimental Therapeutics, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 23635776
2012
  • Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, Barcelona, Spain. · Pubmed 22915752
  • Department of Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology, Pg Vall d'Hebron, Barcelona, Spain. · Pubmed 22407832
2011
  • Experimental Therapeutics Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21278786
7 Other Locations Show
Yearly article counts 06266724500
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.